Integrated analysis of the cerebrospinal fluid peptidome and proteome

Journal of Proteome Research

Volumn 7, Issue 1, 2008, Pages 386-399

  Zougman, Alexandre ^a   Pilch, Bartosz ^a,b   Podtelejnikov, Alexandre ^c   Kiehntopf, Michael ^d   Schnabel, Claudia ^e   Kumar, Chanchal ^a   Mann, Matthias ^a,b  

^a MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c Proxeon A/S   (Denmark)

^d FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^e UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Cerebrospinal fluid; LC MS MS; LTQ Orbitrap; Neuropeptides; Peptidomics; Proteomics

Indexed keywords

MEMBRANE PROTEIN; NEUROPEPTIDE; PEPTIDE DERIVATIVE; PEPTIDOME; PLASMA PROTEIN; PROTEIN PRECURSOR; PROTEOME; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; EXTRACELLULAR SPACE; HUMAN; MASS SPECTROMETRY; NORMAL HUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEIN SECRETION;

CEREBROSPINAL FLUID PROTEINS; HUMANS; MEMBRANE PROTEINS; NEUROPEPTIDES; PEPTIDE HYDROLASES; PEPTIDES; PROTEOMICS; SPINAL PUNCTURE; TANDEM MASS SPECTROMETRY;

EID: 38649136201     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr070501k     Document Type: Article

References (88)

1. Brumback, R. A. Anatomic and physiologic aspects of the cerebrospinal fluid space. In The Cerebrospinal Fluid; Herndon, R. M., Brumback, R. A., Eds.; Kluwer: Boston, 1989; pp 15-43.
2. Thompson, E. J.; Keir, G. Laboratory investigation of cerebrospinal fluid proteins. Ann. Clin. Biochem. 1990, 27 (Pt 5), 425-35.
3. Yuan, X.; Desiderio, D. M. Proteomics analysis of human cerebrospinal fluid. J. Chromatogr. B, Analyt Technol. Biomed. Life Sci. 2005, 815 (1-2), 179-89.
4. Aebersold, R.; Goodlett, D. R. Mass spectrometry in proteomics. Chem. Rev. 2001, 101 (2), 269-95.
5. Geho, D. H.; Liotta, L. A.; Petricoin, E. F.; Zhao, W.; Araujo, R. P. The amplified peptidome: the new treasure chest of candidate biomarkers. Curr. Opin. Chem. Biol. 2006, 10 (1), 50-5.
6. Puchades, M.; Hansson, S. F.; Nilsson, C. L.; Andreasen, N.; Blennow, K.; Davidsson, P. Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease. Brain Res. Mol. Brain Res. 2003, 118 (1-2), 140-6.
7. Zhang, J.; Goodlett, D. R.; Quinn, J. F.; Peskind, E.; Kaye, J. A.; Zhou, Y.; Pan, C.; Yi, E.; Eng, J.; Wang, Q.; Aebersold, R. H.; Montine, T. J. Quantitative proteomics of cerebrospinal fluid from patients with Alzheimer disease. J. Alzheimers Dis. 2005, 7 (2), 125-33, discussion 173-80.
8. Abdi, F.; Quinn, J. F.; Jankovic, J.; Mcintosh, M.; Leverenz, J. B.; Peskind, E.; Nixon, R.; Nutt, J.; Chung, K.; Zabetian, C.; Samii, A.; Lin, M.; Hattan, S.; Pan, C.; Wang, Y.; Jin, J.; Zhu, D.; Li, G. J.; Liu, Y.; Waichunas, D.; Montine, T. J.; Zhang, J. Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders. J. Alzheimers Dis. 2006, 9 (3), 293-348.
9. Dumont, D.; Noben, J. P.; Raus, J.; Stinissen, P.; Robben, J. Proteomic analysis of cerebrospinal fluid from multiple sclerosis patients. Proteomics 2004, 4 (7), 2117-24.
10. Conti, A.; Sanchez-Ruiz, Y.; Bachi, A.; Beretta, L.; Grandi, E.; Beltramo, M.; Alessio, M. Proteome study of human cerebrospinal fluid following traumatic brain injury indicates fibrin(ogen) degradation products as trauma-associated markers. J. Neurotrauma 2004, 21 (7), 854-63.
11. Siman, R.; McIntosh, T. K.; Soltesz, K. M.; Chen, Z.; Neumar, R. W.; Roberts, V. L. Proteins released from degenerating neurons are surrogate markers for acute brain damage. Neurobiol. Dis. 2004, 16 (2), 311-20.
12. Zhang, J.; Goodlett, D. R.; Peskind, E. R.; Quinn, J. F.; Zhou, Y.; Wang, Q.; Pan, C.; Yi, E.; Eng, J.; Aebersold, R. H.; Montine, T. J. Quantitative proteomic analysis of age-related changes in human cerebrospinal fluid. Neurobiol. Aging 2005, 26 (2), 207-27.
13. Yuan, X.; Russell, T.; Wood, G.; Desiderio, D. M. Analysis of the human lumbar cerebrospinal fluid proteome. Electrophoresis 2002, 23 (7-8), 1185-96.
14. Yuan, X.; Desiderio, D. M. Proteomics analysis of prefractionated human lumbar cerebrospinal fluid. Proteomics 2005, 5 (2), 541-50.
15. Finehout, E. J.; Franck, Z.; Lee, K. H. Towards two-dimensional electrophoresis mapping of the cerebrospinal fluid proteome from a single individual. Electrophoresis 2004, 25 (15), 2564-75.
16. Davidsson, P.; Paulson, L.; Hesse, C.; Blennow, K.; Nilsson, C. L. Proteome studies of human cerebrospinal fluid and brain tissue using a preparative two-dimensional electrophoresis approach prior to mass spectrometry. Proteomics 2001, 1 (3), 444-52.
17. Stark, M.; Danielsson, O.; Griffiths, W. J.; Jornvall, H.; Johansson, J. Peptide repertoire of human cerebrospinal fluid: novel proteolytic fragments of neuroendocrine proteins. J. Chromatogr. B, Biomed. Sci. Appl. 2001, 754 (2), 357-67.
18. Yuan, X.; Desiderio, D. M. Human cerebrospinal fluid peptidomics. J. Mass Spectrom. 2005, 40 (2), 176-81.
19. Reiber, H.; Peter, J. B. Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs. J. Neurol. Sci. 2001, 184 (2), 101-22.
20. Thomas, L. Labor und Diagnose Indikation und Bewertung von Laborbefunden für die medizinische Diagnostik, 6th ed.; TH-Books Verlagsgesellschaft:frankfurt/main, 2005.
21. Kluge, H.; Wieczorek, V.; Linke, E.; Zimmermann, K.; Isenmann, S.; Witte, W. O. Atlas of CSF Cytology, 1st ed.; Georg Thieme Verlag: Stuttgart/New York, 2007.
22. Rappsilber, J.; Ishihama, Y.; Mann, M. Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in proteomics. Anal. Chem. 2003, 75 (3), 663-70.
23. Olsen, J. V.; de Godoy, L. M.; Li, G.; Macek, B.; Mortensen, P.; Pesch, R.; Makarov, A.; Lange, O.; Horning, S.; Mann, M. Parts per Million Mass Accuracy on an Orbitrap Mass Spectrometer via Lock Mass Injection into a C-trap. Mol. Cell. Proteomics 2005, 4 (12), 2010-21.
24. Kersey, P. J.; Duarte, J.; Williams, A.; Karavidopoulou, Y.; Birney, E.; Apweiler, R. The International Protein Index: an integrated database for proteomics experiments. Proteomics 2004, 4 (7), 1985-8.
25. Perkins, D. N.; Pappin, D. J.; Creasy, D. M.; Cottrell, J. S. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 1999, 20 (18), 3551-67.
26. Steen, H.; Mann, M. The ABC's (and XYZ's) of peptide sequencing. Nat. Rev. Mol. Cell Biol. 2004, 5 (9), 699-711.
27. Maere, S.; Heymans, K.; Kuiper, M. BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks. Bioinformatics 2005, 21 (16), 3448-9.
28. European Bioinformatics Institute Gene Ontology Annotation (GOA) Database. http://www.ebi.ac.uk/GOA/.
29. Benjamini, Y.; Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. 1995, (B57), 289-300.
30. de Godoy, L. M.; Olsen, J. V.; de Souza, G. A.; Li, G.; Mortensen, P.; Mann, M., Status of complete proteome analysis by mass spectrometry: SILAC labeled yeast as a model system. Genome Biol. 2006, 7 (6), R50.
31. Olsen, J. V.; Macek, B.; Lange, O.; Makarov, A.; Horning, S.; Mann, M. Higher-energy C-trap dissociation for peptide modification analysis. Nat Methods 2007, 4 (9), 709-12.
32. Southey, B. R.; Amare, A.; Zimmerman, T. A.; Rodriguez-Zas, S. L.; Sweedler, J. V. NeuroPred: a tool to predict cleavage sites in neuropeptide precursors and provide the masses of the resulting peptides. Nucleic Acids Res. 2006, 34 (Web Server issue), W267-72.
33. Bergeron, F.; Leduc, R.; Day, R. Subtilase-like pro-protein convertases: from molecular specificity to therapeutic applications. J. Mol. Endocrinol. 2000, 24 (1), 1-22.
34. Eipper, B. A.; Milgram, S. L.; Husten, E. J.; Yun, H. Y.; Mains, R. E. Peptidylglycine alpha-amidating monooxygenase: a multifunctional protein with catalytic, processing, and routing domains. Protein Sci. 1993, 2 (4), 489-97.
35. Desouza, E. B.; Kuhar, M. J. Corticotropin-releasing factors receptors in the pituitary gland and central nervous system: Methods and overview. Methods Enzymol. 1986, 124, 560-590.
36. Fricker, L. D. Neuropeptide-processing enzymes: applications for drug discovery. Aaps J. 2005, 7 (2), E449-55.
37. Abraham, G. N.; Podell, D. N. Pyroglutamic acid: nonmetabolic formation, function in proteins and peptides, and characteristics of the enzymes effecting its removal. Mol. Cell. Biochem. 1981, 38, 181-190.
38. Hinkle, P. M.; Tashjian, A. H., Jr. Receptors for thyrotropin-releasing hormone in prolactin producing rat pituitary cells in culture. J. Biol. Chem. 1973, 248 (17), 6180-6.
39. Neitz, S.; Jurgens, M.; Kellmann, M.; Schulz-Knappe, P.; Schrader, M. Screening for disulfide-rich peptides in biological sources by carboxyamidomethylation in combination with differential matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 2001, 15 (17), 1586-92.
40. Vitt, U. A.; Hsu, S. Y.; Hsueh, A. J. Evolution and classification of cystine knot-containing hormones and related extracellular signaling molecules. Mol. Endocrinol. 2001, 15 (5), 681-94.
41. Mygind, P. H.; Fischer, R. L.; Schnorr, K. M.; Hansen, M. T.; Sonksen, C. P.; Ludvigsen, S.; Raventos, D.; Buskov, S.; Christensen, B.; De Maria, L.; Taboureau, O.; Yaver, D.; Elvig-Jorgensen, S. G.; Sorensen, M. V.; Christensen, B. E.; Kjaerulff, S.; Frimodt-Moller, N.; Lehrer, R. I.; Zasloff, M.; Kristensen, H. H. Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus. Nature 2005, 437 (7061), 975-80.
42. Nyborg, A. C.; Ladd, T. B.; Zwizinski, C. W.; Lah, J. J.; Golde, T. E. Sortilin, SorCS1b, and SorLA Vps10p sorting receptors, are novel gamma-secretase substrates. Mol. Neurodegener. 2006, 1, 3.
43. Kang, J.; Lemaire, H. G.; Unterbeck, A.; Salbaum, J. M.; Masters, C. L.; Grzeschik, K. H.; Multhaup, G.; Beyreuther, K.; Muller-Hill, B. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 1987, 325 (6106), 733-6.
44. Bertagna, X.; Camus, F.; Lenne, F.; Girard, F.; Luton, J. P. Human joining peptide: a proopiomelanocortin product secreted as a homodimer. Mol. Endocrinol. 1988, 2 (11), 1108-14.
45. Fenger, M.; Johnsen, A. H. Alpha-amidated peptides derived from pro-opiomelanocortin in human pituitary tumours. J. Endocrinol. 1988, 118 (2), 329-38.
46. Missler, M.; Sudhof, T. C. Neurexophilins form a conserved family of neuropeptide-like glycoproteins. J. Neurosci. 1998, 18 (10), 3630-8.
47. Mentlein, R. Proline residues in the maturation and degradation of peptide hormones and neuropeptides. FEBS Lett. 1988, 234 (2), 251-6.
48. Yoshihara, M.; Montana, E. S. The synaptotagmins: calcium sensors for vesicular trafficking. Neuroscientist 2004, 10 (6), 566-74.
49. Crambert, G.; Geering, K. FXYD proteins: new tissue-specific regulators of the ubiquitous Na,K-ATPase. Sci. STKE 2003, 2003 (166), RE1.
50. Feschenko, M. S.; Donnet, C.; Wetzel, R. K.; Asinovski, N. K.; Jones, L. R.; Sweadner, K. J. Phospholemman, a single-span membrane protein, is an accessory protein of Na,K-ATPase in cerebellum and choroid plexus. J. Neurosci. 2003, 23 (6), 2161-9.
51. Bhandari, V.; Palfree, R. G.; Bateman, A. Isolation and sequence of the granulin precursor cDNA from human bone marrow reveals tandem cysteine-rich granulin domains. Proc. Natl. Acad. Sci. U.S.A. 1992, 89 (5), 1715-9.
52. Duguay, S. J.; Jin, Y.; Stein, J.; Duguay, A. N.; Gardner, P.; Steiner, D. F. Post-translational processing of the insulin-like growth factor-2 precursor. Analysis of O-glycosylation and endoproteolysis. J. Biol. Chem. 1998, 273 (29), 18443-51.
53. Rinderknecht, E.; Humbel, R. E. Polypeptides with nonsuppressible insulin-like and cell-growth promoting activities in human serum: isolation, chemical characterization, and some biological properties of forms I and II. Proc. Natl. Acad. Sci. U.S.A. 1976, 73 (7), 2365-9.
54. Tian, X. C.; Chen, M. J.; Pantschenko, A. G.; Yang, T. J.; Chen, T. T. Recombinant E-peptides of pro-IGF-I have mitogenic activity. Endocrinology 1999, 140 (7), 3387-90.
55. Higashiyama, S.; Lau, K.; Besner, G. E.; Abraham, J. A.; Klagsbrun, M. Structure of heparin-binding EGF-like growth factor. Multiple forms, primary structure, and glycosylation of the mature protein. J. Biol. Chem. 1992, 267 (9), 6205-12.
56. Miyamoto, S.; Yagi, H.; Yotsumoto, F.; Kawarabayashi, T.; Mekada, E. Heparin-binding epidermal growth factor-like growth factor as a novel targeting molecule for cancer therapy. Cancer Sci. 2006, 97 (5), 341-7.
57. Sakurai, T.; Amemiya, A.; Ishii, M.; Matsuzaki, I.; Chemelli, R. M.; Tanaka, H.; Williams, S. C.; Richardson, J. A.; Kozlowski, G. P.; Wilson, S.; Arch, J. R.; Buckingham, R. E.; Haynes, A. C.; Carr, S. A.; Annan, R. S.; McNulty, D. E.; Uu, W. S.; Terrett, J. A.; Elshourbagy, N. A.; Bergsma, D. J.; Yanagisawa, M. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998, 92 (4), 573-85.
58. de Lecea, L.; Kilduff, T. S.; Peyron, C.; Gao, X.; Foye, P. E.; Danielson, P. E.; Fukuhara, C.; Battenberg, E. L.; Gautvik, V. T.; Bartlett, F. S.; Frankel, W. N.; van den Pol, A. N.; Bloom, F. E.; Gautvik, K. M.; Sutcliffe, J. G. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc. Natl. Acad. Sci. U.S.A. 1998, 95 (1), 322-7.
59. Hungs, M.; Mignot, E. Hypocretin/orexin, sleep and narcolepsy. Bioessays 2001, 23 (5), 397-408.
60. Adachi, J.; Kumar, C.; Zhang, Y.; Olsen, J. V.; Mann, M. The human urinary proteome contains more than 1500 proteins including a large proportion of membranes proteins. Genome Biol. 2006, 7 (9), R80.
61. Pilch, B.; Mann, M., Large-scale and high-confidence proteomic analysis of human seminal plasma. Genome Biol. 2006, 7 (5), R40.
62. de Souza, G. A.; Godoy, L. M.; Mann, M. Identification of 491 proteins in the tear fluid proteome reveals a large number of proteases and protease inhibitors. Genome Biol. 2006, 7 (8), R72.
63. Olsen, J. V.; Mann, M. Improved peptide identification in proteomics by two consecutive stages of mass spectrometric fragmentation. Proc. Natl. Acad. Sci. U.S.A. 2004, 101 (37), 13417-22.
64. Zeeberg, B. R.; Feng, W.; Wang, G.; Wang, M. D.; Fojo, A. T.; Sunshine, M.; Narasimhan, S.; Kane, D. W.; Reinhold, W. C.; Lababidi, S.; Bussey, K. J.; Riss, J.; Barrett, J. C.; Weinstein, J. N. GoMiner: a resource for biological interpretation of genomic and proteomic data. Genome Biol. 2003, 4 (4). R28.
65. Harris, M. A.; Clark, J.; Ireland, A.; Lomax, J.; Ashburner, M.; Foulger, R.; Eilbeck, K.; Lewis, S.; Marshall, B.; Mungall, C.; Richter, J.; Rubin, G. M.; Blake, J. A.; Bult, C.; Dolan, M.; Drabkin, H.; Eppig, J. T.; Hill, D. P.; Ni, L.; Ringwald, M.; Balakrishnan, R.; Cherry, J. M.; Christie, K. R.; Costanzo, M. C.; Dwight, S. S.; Engel, S.; Fisk, D. G.; Hirschman, J. E.; Hong, E. L.; Nash, R. S.; Sethuraman, A.; Theesfeld, C. L.; Botstein, D.; Dolinski, K.; Feierbach, B.; Berardini, T.; Mundodi, S.; Rhee, S. Y.; Apweiler, R.; Barrell, D.; Camon, E.; Dimmer, E.; Lee, V.; Chisholm, R.; Gaudet, P.; Kibbe, W.; Kishore, R.; Schwarz, E. M.; Sternberg, P.; Gwinn, M.; Hannick, L.; Wortman, J.; Berriman, M.; Wood, V.; de la Cruz, N.; Tonellato, P.; Jaiswal, P.; Seigfried, T.; White, R. The Gene Ontology (GO) database and informatics resource. Nucleic Acids Res. 2004, 32 (Database issue), D258-61.
66. Pan, S.; Zhu, D.; Quinn, J. F.; Peskind, E. R.; Montine, T. J.; Lin, B.; Goodlett, D. R.; Taylor, G.; Eng, J.; Zhang, J. A combined dataset of human cerebrospinal fluid proteins identified by multidimensional chromatography and tandem mass spectrometry. Proteomics 2007, 7 (3), 469-73.
67. Huhmer, A. F.; Biringer, R. G.; Amato, H.; Fonteh, A. N.; Harrington, M. G. Protein analysis in human cerebrospinal fluid: Physiological aspects, current progress and future challenges. Dis. Markers 2006, 22 (1-2), 3-26.
68. States, D. J.; Omenn, G. S.; Blackwell, T. W.; Fermin, D.; Eng, J.; Speicher, D. W.; Hanash, S. M. Challenges in deriving high-confidence protein identifications from data gathered by a HUPO plasma proteome collaborative study. Nat. Biotechnol. 2006, 24 (3), 333-8.
69. Blobel, C. P. Remarkable roles of proteolysis on and beyond the cell surface. Curr. Opin. Cell Biol. 2000, 12 (5), 606-12.
70. Pisitkun, T.; Shen, R. F.; Knepper, M. A. Identification and proteomic profiling of exosomes in human urine. Proc. Natl. Acad. Sci. U.S.A. 2004, 101 (36), 13368-73.
71. Selkoe, D. J. Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 2001, 81 (2), 741-66.
72. Haass, C.; De Strooper, B. The presenilins in Alzheimer's disease - proteolysis holds the key. Science 1999, 286 (5441), 916-9.
73. Neumann, S.; Schobel, S.; Jager, S.; Trautwein, A.; Haass, C.; Pietrzik, C. U.; Lichtenthaler, S. F. Amyloid precursor-like protein 1 influences endocytosis and proteolytic processing of the amyloid precursor protein. J. Biol. Chem. 2006, 281 (11), 7583-94.
74. Weber, B.; Schaper, C.; Scholz, J.; Bein, B.; Rodde, C.; Tonner, P. Interaction of the amyloid precursor like protein 1 with the alpha(2A)-adrenergic receptor increases agonist-mediated inhibition of adenylate cyclase. Cell Signal 2006, 18 (10), 1748-1757.
75. Roden, L. Structure and metabolism of connective tissue proteoglycans. In The Biochemistry of Glycoproteins and Proteoglycans, Lennarz, W., Ed.; Plenum Press: NY, 1980; pp 269-314.
76. Kähnert, H.; Paddenberg, R.; Kleesiek, K. Simultaneous secretion of xylosyltransferase and chondroitin sulphate proteoglycane in chondrocyte cultures. Eur. J. Clin. Chem. Clin. Biochem. 1991, 29, 624-625.
77. Kleesiek, K.; Reinards, R.; Okusi, J.; Wolf, B.; Greiling, H. UDP-D-xylose: proteoglycan core protein beta-D-xylosyltransferase: a new marker of cartilage destruction in chronic joint diseases. J. Clin. Chem. Clin. Biochem. 1987, 25 (8), 473-81.
78. Gotting, C.; Sollberg, S.; Kuhn, J.; Weilke, C.; Huerkamp, C.; Brinkmann, T.; Krieg, T.; Kleesiek, K. Serum xylosyltransferase: a new biochemical marker of the sclerotic process in systemic sclerosis. J. Invest. Dermatol. 1999, 112 (6), 919-24.
79. Ghiso, J.; Rostagno, A.; Tomidokoro, Y.; Lashley, T.; Bojsen-Moller, M.; Braendgaard, H.; Plant, G.; Holton, J.; Lal, R.; Revesz, T.; Frangione, B. Genetic alterations of the BRI2 gene: familial British and Danish dementias. Brain Pathol. 2006, 16 (1), 71-9.
80. Vidal, R.; Frangione, B.; Rostagno, A.; Mead, S.; Revesz, T.; Plant, G.; Ghiso, J. A stop-codon mutation in the BRI gene associated with familial British dementia, Nature 1999, 399 (6738), 776-81.
81. Vidal, R.; Revesz, T.; Rostagno, A.; Kim, E.; Holton, J. L.; Bek, T.; Bojsen-Moller, M.; Braendgaard, H.; Plant, G.; Ghiso, J.; Frangione, B. A decamer duplication in the 3′ region of the BRI gene originates an amyloid peptide that is associated with dementia in a Danish kindred. Proc. Natl. Acad. Sci. U.S.A. 2000, 97 (9), 4920-5.
82. Fotinopoulou, A.; Tsachaki, M.; Vlavaki, M.; Poulopoulos, A.; Rostagno, A.; Frangione, B.; Ghiso, J.; Efthimiopoulos, S. BRI2 interacts with amyloid precursor protein (APP) and regulates amyloid beta (Abeta) production. J. Biol. Chem. 2005, 280 (35), 30768-72.
83. Paul, S.; Lombroso, P. J. Receptor and nonreceptor protein tyrosine phosphatases in the nervous system. Cell. Mol. Life Sci. 2003, 60 (11), 2465-82.
84. Harroch, S.; Furtado, G. C.; Brueck, W.; Rosenbluth, J.; Lafaille, J.; Chao, M.; Buxbaum, J. D.; Schlessinger, J. A critical role for the protein tyrosine phosphatase receptor type Z in functional recovery from demyelinating lesions. Nat. Genet. 2002, 32 (3), 411-4.
85. Muller, S.; Kunkel, P.; Lamszus, K.; Ulbricht, U.; Lorente, G. A.; Nelson, A. M.; von Schack, D.; Chin, D. J.; Lotir, S. C.; Westphal, M.; Melcher, T. A role for receptor tyrosine phosphatase zeta in glioma cell migration. Oncogene 2003, 22 (43), 6661-8.
86. Solimena, M.; Dirkx, R., Jr.; Hermel, J. M.; Pleasic-Williams, S.; Shapiro, J. A.; Caron, L.; Rabin, D. U. ICA 512, an autoantigen of type I diabetes, is an intrinsic membrane protein of neurosecretory granules. EMBO J. 1996, 15 (9), 2102-14.
87. Sun, Q. L.; Wang, J.; Bookman, R. J.; Bixby, J. L. Growth cone steering by receptor tyrosine phosphatase delta defines a distinct class of guidance cue. Mol. Cell Neurosci. 2000, 16 (5), 686-95.
88. Zhang, Y.; Adachi, J.; Olsen, J. V.; Shi, R.; de Souza, G.; Pasini, E.; Foster, L. J.; Macek, B.; Zougman, A.; Kumar, C.; Wisniewski, J. R.; Jun, W.; Mann, M., MAPU: Max-Planck Unified database of organellar, cellular, tissue and body fluid proteomes. Nucleic Acids Res. 2006.